Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction: Results From GISSI-3 Trial

By Franzosi M.G.   Maggioni A.P.   Santoro E.   Tognoni G.   Cavalieri E.  

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 337-346

Adis International

Access to resources Recommend Favorite

A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction

By Lamotte Mark  

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 783-795

Adis International

Access to resources Recommend Favorite

Anti-Arrhythmic Properties of N-3 Poly-Unsaturated Fatty Acids (n-3 PUFA)

By  

Current Medicinal Chemistry, Vol. 14, Iss. 19, 2007-08 ,pp. : 2070-2080

Bentham Science Publishers

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction: Economic Evaluation of the Acute Infarction Ramipril Efficacy (AIRE) Study for Germany from the Perspective of Statutory Health Insurance

By Schädlich P.K.  

PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. : 653-669

Adis International

Access to resources Recommend Favorite

Effects of different dietary omega-6/3 polyunsaturated fatty acids ratios on infarct size and the limbic system after myocardial infarction

By Rondeau I.   Picard S.   Bah T. M.   Roy L.   Godbout R.   Rousseau G.  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 3, 2011-03 ,pp. : 169-176

NRC Research Press

Access to resources Recommend Favorite